Skip to content
Chronos Biosciences
Phase 1 State-of-the-art review

A biotechnology company working on the reversal of human ageing.

Chronos Biosciences is at an early stage. The work under way is to review the published evidence across the active fronts of the field, document the scope and limitations of each one, and establish evaluation criteria before starting experimental work of our own.

Focus
01

Focus

The field currently works across several fronts with solid preclinical evidence and uneven clinical progress. Chronos Biosciences follows four of them, plus a fifth, cross-cutting problem that constrains all the others.

Area 01

Senescent burden

Selective clearance of senescent cells that sustain chronic inflammation in aged tissue.

Area 02

Chronic inflammation

Signalling by cytokines associated with age-dependent fibrosis and inflammation.

Area 03

Extracellular matrix

Stiffness of the tissue niche and its effect on regenerative capacity.

Area 04

Cofactor metabolism

Availability of the substrate consumed by the enzymes of epigenetic maintenance.

Cross-cutting problem

Measurement

No validated functional endpoint exists for rejuvenation interventions in humans. It is the problem that constrains the evaluation of every other one.

02

What being in Phase 1 means

There is no laboratory, no trials under way and no results of our own. The work of this phase is documentary and methodological, and it produces criteria rather than molecules.

  1. 01

    Read the actual frontier

    What has been demonstrated, in which species, with what endpoint and at what effect size. The review is done against the primary source, not against popular accounts.

  2. 02

    Document the limitations

    Every line of work in the field has a limit described in its own literature. It is recorded alongside the evidence, not separately.

  3. 03

    Set evaluation criteria

    Which result would make us abandon a hypothesis, decided and written down before anything is run.

  4. 04

    Publish the method

    The articles on this site are the visible output of the phase. Every figure states where it comes from and in which model it was obtained.

03

Articles

We write about the state of the field and about the method we use to review it. No calendar: articles are published once reference verification is complete.

See all articles →

04

Working with us

There are no open hiring processes. There is interest in talking to researchers, laboratories and contract research organisations.

  • 01Research. Cellular senescence, extracellular matrix, NAD⁺ metabolism and partial reprogramming.
  • 02Laboratories and CROs. Execution and quotation of experimental designs in human cell models.
  • 03Measurement methodology. Development or validation of functional endpoints.
  • 04Corrections. Citation errors or prior work not covered in what we publish.